Search results

Hallucinogens, Psychedelics, Entactogens: Challenges Associated With Schedule 1 Therapeutic Development

Sep 10, 2021

• Preclinical Research
• Clinical Trials
• Manufacturing and Analytical Services

Planning Your First-in-Human Trial

Aug 27, 2021

• Clinical Trials

Hybrid Medicines and 505(b)(2) NDA Approval Pathways

Dec 1, 2018

• Regulatory Affairs
• End-to-End Program

Scientific Publication

Accelerating Decision-Ready Hepatic PK Data: Adaptive Strategy and Integrated Execution Deliver LPE 19 Days Early

Sep 10, 2026

• CRO Services
• Clinical Trials

Scientific Publication

Project and Program Management Services―Clear Oversight at Every Stage

Aug 17, 2026

• CRO Services
• Clinical Trials
• Preclinical Research

Scientific Publication

IND and CTA Submission Principles and Timelines

Jun 16, 2026

• CRO Services

Scientific Publication

Regulatory Pathways by Region―A Comparative Table

Jun 3, 2026

• CRO Services
• Clinical Trials
• Preclinical Research
• Bioanalysis